| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
24,090 | 15,725 | 26,424 | 42,486 | 31,310 | 14,329 | 7,935 |
General and administrative | ||||||
7,143 | 5,269 | 7,635 | 10,277 | 6,200 | 7,449 | 1,990 |
Total operating expenses | ||||||
31,233 | 20,994 | 34,059 | 52,763 | 37,510 | 21,778 | 9,925 |
Loss from operations | ||||||
-31,233 | -20,994 | -34,059 | -52,763 | -37,510 | -21,778 | -9,925 |
Other income (loss): | ||||||
Interest income | ||||||
564 | 400 | 354 | 49 | 0 | 1 | 1 |
Gain from Janssen Transaction | ||||||
750,000 | - | - | - | - | - | - |
Other income | ||||||
10 | 4 | - | - | 21 | 0 | 0 |
Foreign exchange loss | ||||||
-888 | -548 | 555 | -47 | 6 | 53 | -3 |
Total other income (loss) | ||||||
749,686 | -144 | 909 | 2 | 27 | 54 | -2 |
Loss before income taxes | ||||||
718,453 | -21,138 | -33,150 | - | - | - | - |
Provision for income taxes | ||||||
49,824 | - | - | - | - | - | - |
Net loss | ||||||
668,629 | -21,138 | -33,150 | -52,761 | -37,483 | -21,724 | -9,927 |
Net income (loss) per share—basic (in dollars per share) | ||||||
17.17 | -0.59 | -0.95 | - | - | - | - |
Shares used to compute basic net income (loss) per share (in shares) | ||||||
38,945 | 35,804 | 34,875 | - | - | - | - |
Net income (loss) per share—diluted (in dollars per share) | ||||||
14.44 | -0.59 | -0.95 | - | - | - | - |
Shares used to compute diluted net income (loss) per share (in shares) | ||||||
46,319 | 35,804 | 34,875 | - | - | - | - |
Net loss per share—basic and diluted (in dollars per share) | ||||||
- | - | - | -1.63 | -1.22 | -0.90 | -0.45 |
Weighted-average number of common shares—basic and diluted (in shares) | ||||||
- | - | - | 32,403 | 30,801 | 24,162 | 22,220 |